BIOE — Bio Essence Corp
—
OTC ·
Health Care ·
Pharmaceuticals ·
CIK 1723059 ·
Last close
$0.47
Market Cap
$25.29M
52W High
$0.52
52W Low
$0.05
ADV30
7,983
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | 794,711 | 470,261 | 279,290 | 270,077 | 4,002,945 | 675 | 1,660,388 |
| Mar 2026 | 500,537 | 319,353 | 215,795 | 205,373 | 789,032 | 36,177 | 2,216,552 |
| Dec 2025 | 1,479,454 | 1,143,421 | 1,029,627 | 1,029,087 | 422,474 | 0 | 2,495,367 |
| Sep 2025 | 136,800 | 95,760 | 14,253 | 12,998 | 184,534 | 28,741 | 3,286,514 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$1,075,705
Investing CF
—
Financing CF
$-990,203
CapEx
—
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$0.00
As of
2026-11-15
Balance + Analyst (yfinance extras)
Retained Earnings
$-9,077,623
Inventory
—
Receivables
$595,832
ST Investments
—
EBIT TTM
$1,538,225
Pretax Income TTM
$1,537,785
Interest Exp TTM
$2,185
Analysts
—
Yahoo Snapshot (yfinance, live)
Total Revenue
$2,911,502
EBITDA
$1,642,741
Free Cash Flow
$25,637
Enterprise Value
$11,355,225
Total Cash
$675
Total Debt
$1,568,043
Shares Out
53,809,000
Trailing EPS
$0.03
Book Value
$-0.06
ROE
—
ROA
46.7%
Div Yield
0.00%
Annual Trend (SEC EDGAR, last 5y)
Revenues vs Net Income (last 5y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 1,897,566 | 900,011 | 896,197 | 422,474 | 2,495,367 | -2,072,893 | 1,569,753 |
| Dec 2024 | 323,940 | -459,438 | -1,308,796 | 281,024 | 3,250,114 | -2,969,090 | 623,865 |
| Dec 2023 | 0 | -345,590 | -971,879 | 2,758,580 | 4,418,874 | -1,660,294 | -1,025,673 |
| Dec 2022 | 621,590 | -511,138 | -809,679 | 1,547,725 | 4,786,140 | -3,238,415 | -703,241 |
| Dec 2021 | — | — | — | — | — | — | — |
TTM Snapshot
Revenues TTM
$2,911,502
NetIncome TTM
$1,517,535
OpCashFlow TTM
—
Assets (Latest)
$4,002,945
Forward EPS
—
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| ABVC | ABVC BIOPHARMA, INC. | $25.36M | $0.94 | — |
| AARD | Aardvark Therapeutics, Inc. | $25.17M | $1.15 | — |
| CLCS | Cell Source, Inc. | $25.14M | $0.37 | — |
| BETRF | BetterLife Pharma Inc. | $25.64M | $0.15 | — |
| ACET | Adicet Bio, Inc. | $26.03M | $2.78 | — |
News headlines (Yahoo Finance, 1h cache)
Bio Essence Unveils Practitioner-Controlled Knowledge Vault, Tackling AI's Trust Barrier in Healthcare
2026-10-29 12:00 · Yahoo
Bio Essence Corp Appoints Xiying (Thea) Zhang and Geoff Fellows as Independent Directors to Its Board
2026-10-26 12:00 · Yahoo
Bio Essence Corporation Expands MediFlow Platform with Development of Practitioner-Specific AI and RAG Technology
2026-10-15 12:00 · Yahoo
Bio Essence Corporation (OTCQB: BIOE) to Acquire MediFlow AI Platform, Strengthening Its Human Health and Wellness Portfolio
2026-04-27 12:00 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.